Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $14.87 USD
Change Today +0.02 / 0.13%
Volume 914.6K
FOLD On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - amicus therapeutics inc (FOLD)

Name (Connections)Board RelationshipsTitleKey Developments
Glenn Sblendorio MBA 50 RelationshipsDirector and Chairman of Audit Committee 
Michael Raab 26 RelationshipsIndependent Director, Member of Audit Committee and Member of Compensation Committee 
Robert Essner 78 RelationshipsDirector and Member of Audit Committee 

Compensation Committee* - amicus therapeutics inc (FOLD)

Name (Connections)Board RelationshipsTitle
Sol Barer Ph.D. 143 RelationshipsDirector and Member of Compensation Committee
Margaret McGlynn R.Ph 47 RelationshipsDirector, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Michael Raab 26 RelationshipsIndependent Director, Member of Audit Committee and Member of Compensation Committee
FOLD Compensation vs. Industry
561.4K
354.2K
Chief Executive Officer
351.0K
263.2K
Chief Financial Officer
387.0K
345.4K
Chief Operating Officer
Share price activity for AMICUS THERAPEUTICS INC (FOLD)
52 Week Price Performance
FOLD
Industry Average

Nominating Committee* - amicus therapeutics inc (FOLD)

Name (Connections)Board RelationshipsTitleKey Developments
Donald Hayden Jr. 89 RelationshipsLead Independent Director and Chairman of Nominating & Corporate Governance CommitteeAmicus Therapeutics, Inc. Announces Executive Changes
06/8/15
Margaret McGlynn R.Ph 47 RelationshipsDirector, Chairman of Compensation Committee and Member of Nominating & Corporate Governance CommitteeAmicus Therapeutics Appoints David Allsop as Senior Vice President, International
04/27/15
Ted Love M.D. 77 RelationshipsDirector, Member of Nominating & Corporate Governance Committee and Member of Science & Technology CommitteeJames N. Topper Not to Seek for Re-Election to the Board of Amicus Therapeutics
04/13/15

Corporate Governance Committee* - amicus therapeutics inc (FOLD)

Name (Connections)Board RelationshipsTitle
Donald Hayden Jr. 89 RelationshipsDirector and Member of Compensation Committee
Ted Love M.D. 77 RelationshipsDirector, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Margaret McGlynn R.Ph 47 RelationshipsIndependent Director, Member of Audit Committee and Member of Compensation Committee
FOLD and Competitor
Insiders vs. External
Board
6%
94%
Amicus Therapeutics, Inc.
Insiders
External Board Members

Advisory Committee* - amicus therapeutics inc (FOLD)

Name (Board Relationships)/Title Board Affiliations
Michel Bouvier 23 Relationships
Member of Scientific Advisory Board
No other board affiliations
Barry Byrne 37 Relationships
Member of Scientific Advisory Board
No other board affiliations
Dominique Germain 15 Relationships
Member of Medical Advisory Board
No other board affiliations
Stuart Kornfeld 15 Relationships
Member of Scientific Advisory Board
No other board affiliations
Pramod Mistry 15 Relationships
Member of Medical Advisory Board
No other board affiliations
Marc Patterson 15 Relationships
Member of Medical Advisory Board
No other board affiliations
Gregory Petsko 94 Relationships
Member of Scientific Advisory Board
No other board affiliations
Thomas Voit 19 Relationships
Member of Medical Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FOLD:US $14.87 USD +0.02

FOLD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for FOLD.
View Industry Companies
 

Industry Analysis

FOLD

Industry Average

Valuation FOLD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5,074.8x
Price/Book 5.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4,786.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMICUS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.